Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $13
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $11 to $13.
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $11 to $13.